ICA Medical Advisory Council
The ICA Medical Advisory Council (MAC) dedicates their time, expertise, and enthusiasm to ensuring ICA mission fulfillment.
Meet the ICA Medical Advisory Council
The Interstitial Cystitis Association Medical Advisory Council (MAC) consists of leaders in interstitial cystitis health care and research and provides the ICA with medical and scientific expertise to advance the ICA mission.
Keith Blevins, BSN, RN
Keith Blevins, BSN, RN, is a registered nurse specializing in urology and voiding dysfunction with a focus on complex bladder conditions, including interstitial cystitis/bladder pain syndrome. He works in a physician group practice, assisting with diagnostic and procedural urologic care, including cystoscopy, bladder instillations, and urodynamic evaluation. In addition to his clinical work, he is an educator who teaches nursing students and develops clinical training resources to improve recognition and management of complex genitourinary disorders. He is based in Northern California and manages patients in rural settings.
Jennifer Fariello Moldwin, MSN, MEd, WHNP-BC
Jennifer Fariello Moldwin, MSN, MEd, WHNP-BC, is Nurse Practitioner for Female Pelvic, Urogenital Pain and Sexual Medicine in Urogynecology at Northwell Health located at offices in Bay Shore and Syosset, NY. Â She has been diagnosing and treating women with pelvic and/or sexual pain caused by interstitial cystitis/bladder pain syndrome, pelvic floor dysfunction, vulvodynia, vulvar dermatoses, recurrent vaginal and/or urinary tract infections for over 20 years. Ms. Fariello Moldwin has been involved in numerous research studies and has published extensively on these chronic pain conditions.
Robert Moldwin, MD, FACS
Dr. Moldwin is Professor of Urology at the Zucker School of Medicine at Hofstra-Northwell. He is also Director of the Pelvic Pain Treatment Center at The Arthur Smith Institute for Urology of the Northwell Health System. Dr. Moldwin has a national and international reputation as a leader in the field of pelvic pain with special interests in pain syndromes including interstitial cystitis/bladder pain syndrome and chronic prostatitis/chronic pelvic pain syndrome. He has published extensively in peer-reviewed journals some of which have included Cancer, The Journal of Urology, The British Journal of Urology International, The British Medical Journal, Contemporary Urology, and Urology. Dr. Moldwin is the author of the well-received, “The Interstitial Cystitis Survival Guide: Your Guide to the Latest Treatment Options and Coping Strategies,” the first physician-written book exclusively related to interstitial cystitis, designed to reach an audience comprised of both physicians and patients. He also has recently edited a physician-oriented textbook entitled "Urological And Gynaecological Chronic Pelvic Pain."
Kristi Ninnemann, PhD, MPH, MA
Kristi Ninnemann, PhD, MPH, MA, is a Licensed Professional Counselor in Ohio with more than 25 years of experience in crisis response, community mental health, behavioral health research, and higher education. She currently serves as Postvention Program Manager at NAMI Greater Cleveland, where she supports individuals and communities impacted by suicide. Kristi earned a Master’s degree in Community Counseling in 1999 and worked as a mental health practitioner from 1997 to 2008, specializing in diagnostic and emergency department–based crisis assessment. Seeking to broaden her impact on the care and treatment of individuals with mental illness, she returned to graduate school and earned a Master of Public Health from Case Western Reserve University in 2014, followed by a PhD in Medical Anthropology from CWRU in 2025. Her scholarly and clinical work examines how individuals experience and navigate psychiatric illness and care, with particular attention to the personal, cultural, and structural factors that shape treatment and recovery. An adjunct faculty member teaching undergraduate, graduate, and professional students in psychology and medicine, Kristi is committed to elevating lived experience as a critical form of knowledge and to fostering more responsive, patient-centered approaches to mental health care.
Jill M. Peters-Gee, MD
Jill M. Peters-Gee, M.D. is a board-certified Urologist with over three decades of experience. A graduate of the University of Michigan Medical School, she was the first female in her residency program, and one of the first 50 board certified Urologists in the country. She has dedicated her career to Women’s health and to the care of patients with Interstitial Cystitis and Bladder Pain Syndrome (IC/BPS). Her expertise is deeply rooted in both clinical practice and research. Since her retirement from clinical practice in 2022, Dr. Peters-Gee’s commitment to the IC/BPS community persists. She continues to contribute, by founding and facilitating the Connecticut IC/BPS support group and she has written her first book “IC Journey to Wellness.” A resident of Connecticut, she enjoys life with her husband, cherishing their roles as parents to four and grandparents to three, while still finding time for travel, volunteering, fly-fishing, and gardening.
Jeffrey G. Proctor, M.D.
Dr. Proctor’s areas of urologic expertise are interstitial cystitis, overactive bladder, bladder Botox, Axonics, and InterStim Therapy. Dr. Proctor has been involved in national research protocols, including an interstitial cystitis (IC) study, where he served as principal investigator for a national, multi-center study. Dr. Proctor is board-certified by the American Board of Urology and is a member of the American Urological Association, Southeastern Section of the American Urological Association, Society for Infection and Inflammation in Urology, and the GAG Society. He also serves on the Board of the Cobb County Medical Society.  Dr. Proctor has been named as President of the Society for Infection and Inflammation in Urology (2013-2104). He is also a member of the Interstitial Cystitis Association’s (ICA) Medical Advisory Board and served as MD Chair of a continuing medical education (CME) program. The program, titled Conquering IC: Identification and Management Strategies, helps educate healthcare providers on the signs and symptoms of IC so they can confidently recognize and treat IC patients.
Raveen Syan, MD, FPMRS
Dr. Syan earned her medical degree at the University of Southern California, Keck School of Medicine (2008-2012) and completed her Urologic Surgery residency at New York University, Langone Medical Center (2012-2017). She completed an ACGME-accredited fellowship at Stanford University in Female Pelvic Medicine and Reconstructive Surgery (2017-2019). As a fellow, she pursued specialized research interests, specifically in the fields of stress urinary incontinence, pelvic organ prolapse, overactive bladder, and health disparities in pelvic floor disorders.Â
As an Associate Professor of Clinical Urology at the University of Miami Miller School of Medicine since 2019 and current Director of Female Pelvic Medicine and Reconstructive Surgery at the Desai Sethi Urology Institute, she cares for women with complex pelvic floor disorders, including pelvic pain syndrome, interstitial cystitis, pelvic organ prolapse, urinary incontinence, and neurogenic bladder.Â
Pradeep Tyagi, PhD
Dr. Tyagi is a NIH funded translational researcher focused on diagnosis, prognosis, and treatment of interstitial cystitis/bladder pain syndrome (IC/BPS) at the University of Pittsburgh. He began his research journey with PhD dissertation on intravesical drug delivery for IC in 2005 and his pharmacist training with a master’s degree in pharmacology equipped him to steer the manufacturing of liposomes for clinical trial on IC/BPS patients. Dr. Tyagi is a research associate professor of urology and his expertise in pharmacology propels the repurposing of FDA approved drugs (Tacrolimus, Misoprostol, Acotiamide, Ivabradine…) for accelerated translation. In addition to therapeutic use, Dr. Tyagi also repurposed FDA approved contrast agents (Gadobutrol and Ferumoxytol) for intravesical contrast enhanced magnetic resonance imaging (ICE-MRI), a novel technique for virtual measurement of bladder permeability of rodents and IC/BPS patients. He led the research on urine levels of chemokines as potential molecular signatures to complement the patient reported outcomes of disease severity.